Overview

Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of switching Atripla to Eviplera on neurocognition measured by neuropsychological testing and functional MRI
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
Gilead Sciences
Treatments:
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Emtricitabine
Rilpivirine
Tenofovir